This is the standing evidence sheet for Vertex Pharmaceuticals Inc / Ma (VRTX): the yardsticks BullScope computes from official SEC filings and market prices. It refreshes whenever a new edition of our research is published, and it is impersonal by design, every reader sees the same page. Nothing here is investment advice; it is the evidence, organized.
The price tag: what buyers pay per dollar of profit
Today the market pays about $35.1 for each $1 of Vertex Pharmaceuticals Inc / Ma’s annual profit (a price-to-earnings ratio of 35.1). Across its own past decade the typical price tag was 31.0, which puts today at roughly the 97th percentile of the company’s own history.
The tape: what the stock itself has done
- Last price: $552.85 (end-of-day market data as of the edition date · methodology) · 0% below its 52-week high
- Past 6 months: +13.4% · past 12 months: +39.9%
- Day-to-day temperament: jumpy (annualized volatility 28%)
The filed record: straight from the annual reports
| Fiscal year | Revenue | Growth | Operating margin | EPS |
|---|---|---|---|---|
| FY2021 | $7.6B | , | 36.7% | $9.01 |
| FY2022 | $8.9B | +17.9% | 48.2% | $12.82 |
| FY2023 | $9.9B | +10.5% | 38.8% | $13.89 |
| FY2024 | $11.0B | +11.7% | -2.1% | $-2.08 |
| FY2025 | $12.0B | +8.9% | 34.8% | $15.32 |
The road ahead: filed results vs published expectations
| FY2023A | FY2024A | FY2025A | FY2026E | FY2027E | FY2028E | |
|---|---|---|---|---|---|---|
| Net sales ($B) | 9.9 | 11.0 | 12.0 | 13.1 to 13.2 | 13.5 to 15.0 | 14.5 to 17.0 |
| Net sales growth (%) | +10.4 | +11.1 | +9.1 | 9 to 10 | 3 to 14 | 7 to 13 |
| Operating margin (%) | 38.4 | -1.8 | 35.0 | 33 to 36 | 31 to 37 | 32 to 38 |
| Diluted EPS ($) | 13.89 | -2.08 | 15.32 | 15.50 to 17.50 | 14.00 to 19.50 | 15.00 to 23.00 |
Columns marked A are actual filed results; E columns are the published consensus ranges the current price is being weighed against.
The four gauges: from the latest edition
BullScope coverage of Vertex Pharmaceuticals Inc / Ma
Read the full report on Vertex Pharmaceuticals Inc / Ma in the BullScope Terminal → It opens with this company loaded.
Edition date: 2026-08-21. This page updates when a new edition is published. Sources: SEC EDGAR filings, Nasdaq prices; computed by BullScope’s published methodology.
